Exonic deletions of FXN and early-onset Friedreich ataxia
- PMID: 22409940
- DOI: 10.1001/archneurol.2011.834
Exonic deletions of FXN and early-onset Friedreich ataxia
Abstract
Background: Friedreich ataxia (FA) is the most frequent type of autosomal recessive cerebellar ataxia, occurring at a mean age of 16 years. Nearly 98% of patients with FA present with homozygous GAA expansions in the FXN gene. The remaining patients are compound heterozygous for an expansion and a point mutation. Patients who are compound heterozygous for an exonic deletion and an expansion are exquisitely rare.
Objectives: To describe 6 patients affected with FA due to an exonic deletion mutation (FAexdel) and to compare these 6 patients with FAexdel with 46 patients consecutively diagnosed with typical FA due to homozygous GAA expansion and whose small expansions were within the same range as that of the expansions of the patients with FAexdel.
Design: Description of a series.
Setting: Academic research.
Patients: Six patients with FAexdel and 46 patients with typical FA.
Intervention: FXN gene analysis, including assessments of GAA expansion and exon sequencing and determination of exonic copy numbers using multiplex ligation-dependent probe amplification.
Results: We identified 6 patients with FA who presented with the combination of 1 GAA expansion and 1 FXN exonic deletion. The mean (SD) age at onset of the disease was earlier for patients with FAexdel (7 [4] years [range, 3-12 years]) than for patients with typical FA (15 [5] years [range, 6-30 years]) (P = .001), and the median time to confinement to wheelchair was shorter for patients with FAexdel (20 years) than for patients with typical FA (28 years) (P = .002). There was no difference between the mean (SD) size of the expansion for the patients with FAexdel (780 [256] GAA triplet repeat sequences [range, 340-1070 GAA triplet repeat sequences]) and the mean (SD) size of the short expansion for the patients with typical FA (634 [163] GAA triplet repeat sequences [range, 367-1000 GAA triplet repeat sequences]) (P = .10). The mean disease duration before becoming wheelchair bound was shorter for patients with FAexdel (9 years) than for patients with typical FA (13 years), and the incidence of cardiomyopathy was higher for patients with FAexdel (84%) than for patients with typical FA (68%). However, these differences were not significant, probably owing to the small size of the FAexdel group. The other extraneurological signs, such as scoliosis or diabetes mellitus, were particularly frequently observed in the FAexdel group. One patient presented at 9 years of age with severe angina and marked cardiomyopathy that confined her to a wheelchair. Three patients had disabling autonomic disturbances. It appears that exonic deletion significantly contributes to the clinical picture of patients with FA.
Conclusions: Friedreich ataxia due to an exonic deletion mutation corresponds to an early onset and severe variant of FA. FXN should be investigated for exonic deletion in patients with early-onset FA in which only 1 GAA expansion without a point mutation is found. Patients with FAexdel have to be carefully observed using cardiological, orthopaedic, endocrinological, gastroenterological, and ophthalmological data. Friedreich ataxia due to an exonic deletion mutation should be suspected in young patients presenting with severe scoliosis.
Similar articles
-
Friedreich ataxia: Detection of GAA repeat expansions and frataxin point mutations.Methods Mol Med. 2006;126:197-216. doi: 10.1385/1-59745-088-X:197. Methods Mol Med. 2006. PMID: 16930014
-
FXN methylation predicts expression and clinical outcome in Friedreich ataxia.Ann Neurol. 2012 Apr;71(4):487-97. doi: 10.1002/ana.22671. Ann Neurol. 2012. PMID: 22522441
-
Identification and sizing of GAA trinucleotide repeat expansion, investigation for D-loop variations and mitochondrial deletions in Iranian patients with Friedreich's ataxia.Mitochondrion. 2006 Apr;6(2):82-8. doi: 10.1016/j.mito.2006.01.005. Epub 2006 Apr 3. Mitochondrion. 2006. PMID: 16581313
-
[Friedreich ataxia with GAA repeat expansion: molecular mechanism and clinical feature].Nihon Rinsho. 1999 Apr;57(4):960-6. Nihon Rinsho. 1999. PMID: 10222797 Review. Japanese.
-
Striking intrafamilial phenotypic variability and spastic paraplegia in the presence of similar homozygous expansions of the FRDA1 gene.Mov Disord. 2004 Dec;19(12):1424-31. doi: 10.1002/mds.20264. Mov Disord. 2004. PMID: 15514925 Review.
Cited by
-
Friedreich Ataxia: Multidisciplinary Clinical Care.J Multidiscip Healthc. 2021 Jun 28;14:1645-1658. doi: 10.2147/JMDH.S292945. eCollection 2021. J Multidiscip Healthc. 2021. PMID: 34234452 Free PMC article. Review.
-
High-throughput immunoassay for the biochemical diagnosis of Friedreich ataxia in dried blood spots and whole blood.Clin Chem. 2013 Oct;59(10):1461-9. doi: 10.1373/clinchem.2013.207472. Epub 2013 Jul 9. Clin Chem. 2013. PMID: 23838345 Free PMC article.
-
Prediction of the disease course in Friedreich ataxia.Sci Rep. 2022 Nov 10;12(1):19173. doi: 10.1038/s41598-022-23666-z. Sci Rep. 2022. PMID: 36357508 Free PMC article.
-
Uniparental IsoDisomy: a case study on a new mechanism of Friedreich ataxia.Eur J Hum Genet. 2025 Jan;33(1):137-140. doi: 10.1038/s41431-024-01728-2. Epub 2024 Nov 4. Eur J Hum Genet. 2025. PMID: 39496895
-
Clinical use of frataxin measurement in a patient with a novel deletion in the FXN gene.J Neurol. 2013 Apr;260(4):1116-21. doi: 10.1007/s00415-012-6770-5. Epub 2012 Nov 30. J Neurol. 2013. PMID: 23196337
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous